1. Home
  2. ATYR vs NEON Comparison

ATYR vs NEON Comparison

Compare ATYR & NEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • NEON
  • Stock Information
  • Founded
  • ATYR 2005
  • NEON 1997
  • Country
  • ATYR United States
  • NEON Sweden
  • Employees
  • ATYR N/A
  • NEON N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • NEON Industrial Machinery/Components
  • Sector
  • ATYR Health Care
  • NEON Technology
  • Exchange
  • ATYR Nasdaq
  • NEON Nasdaq
  • Market Cap
  • ATYR 451.3M
  • NEON 428.0M
  • IPO Year
  • ATYR 2015
  • NEON 2007
  • Fundamental
  • Price
  • ATYR $5.48
  • NEON $25.18
  • Analyst Decision
  • ATYR Strong Buy
  • NEON Strong Buy
  • Analyst Count
  • ATYR 6
  • NEON 1
  • Target Price
  • ATYR $20.20
  • NEON $16.50
  • AVG Volume (30 Days)
  • ATYR 3.6M
  • NEON 738.7K
  • Earning Date
  • ATYR 08-12-2025
  • NEON 08-07-2025
  • Dividend Yield
  • ATYR N/A
  • NEON N/A
  • EPS Growth
  • ATYR N/A
  • NEON N/A
  • EPS
  • ATYR N/A
  • NEON N/A
  • Revenue
  • ATYR N/A
  • NEON $2,807,000.00
  • Revenue This Year
  • ATYR $960.85
  • NEON N/A
  • Revenue Next Year
  • ATYR $1,283.47
  • NEON $39.01
  • P/E Ratio
  • ATYR N/A
  • NEON N/A
  • Revenue Growth
  • ATYR N/A
  • NEON N/A
  • 52 Week Low
  • ATYR $1.51
  • NEON $2.22
  • 52 Week High
  • ATYR $5.98
  • NEON $28.08
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 56.44
  • NEON 67.33
  • Support Level
  • ATYR $4.96
  • NEON $19.87
  • Resistance Level
  • ATYR $5.45
  • NEON $28.08
  • Average True Range (ATR)
  • ATYR 0.36
  • NEON 2.16
  • MACD
  • ATYR -0.06
  • NEON 0.31
  • Stochastic Oscillator
  • ATYR 60.42
  • NEON 68.55

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About NEON Neonode Inc.

Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, but not limited to, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in the United States, Japan, South Korea, Germany, Sweden, China, and other regions. A majority of its revenue is generated from Japan.

Share on Social Networks: